SSU72L5
gene geneOn this page
Summary
SSU72L5 (SSU72 like 5, HGNC:43624) is a protein-coding gene on chromosome 11p15.4, encoding RNA polymerase II subunit A C-terminal domain phosphatase SSU72 like protein 5 (A0A1W2PQ64). Protein phosphatase that catalyzes the dephosphorylation of the C-terminal domain of RNA polymerase II.
Predicted to enable RNA polymerase II CTD heptapeptide repeat phosphatase activity. Predicted to be involved in termination of RNA polymerase II transcription. Predicted to be located in nucleus. Predicted to be part of mRNA cleavage and polyadenylation specificity factor complex.
Source: NCBI Gene 196120 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001414002
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43624 |
| Approved symbol | SSU72L5 |
| Name | SSU72 like 5 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000284018 |
| Ensembl biotype | protein_coding |
| Entrez | 196120 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000639584
RefSeq mRNA: 1 — MANE Select: NM_001414002
NM_001414002
Canonical transcript exons
ENST00000639584 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003808356 | 4233217 | 4234287 |
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 37.20.
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 36.09 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 33.16 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 32.17 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| liver | UBERON:0002107 | 30.70 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| lymph node | UBERON:0000029 | 29.36 | silver quality |
| prefrontal cortex | UBERON:0000451 | 29.27 | gold quality |
| gall bladder | UBERON:0002110 | 28.91 | silver quality |
| monocyte | CL:0000576 | 28.87 | silver quality |
| right lobe of liver | UBERON:0001114 | 28.37 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| rectum | UBERON:0001052 | 26.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.07 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 25.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 24.66 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ssu72 | ENSDARG00000031216 |
| drosophila_melanogaster | Ssu72 | FBGN0031054 |
| caenorhabditis_elegans | WBGENE00020480 |
Paralogs (6): SSU72 (ENSG00000160075), SSU72L6 (ENSG00000230268), SSU72L4 (ENSG00000283873), SSU72L2 (ENSG00000284306), SSU72L1 (ENSG00000284438), SSU72L3 (ENSG00000284546)
Protein
Protein identifiers
RNA polymerase II subunit A C-terminal domain phosphatase SSU72 like protein 5 — A0A1W2PQ64 (reviewed: A0A1W2PQ64)
Alternative names: RNA polymerase II subunit A C-terminal domain phosphatase SSU72L5
All UniProt accessions (1): A0A1W2PQ64
UniProt curated annotations — full annotation on UniProt →
Function. Protein phosphatase that catalyzes the dephosphorylation of the C-terminal domain of RNA polymerase II. Plays a role in RNA processing and termination.
Subcellular location. Nucleus.
Similarity. Belongs to the SSU72 phosphatase family.
RefSeq proteins (1): NP_001400931* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006811 | RNA_pol_II_suA | Family |
| IPR036196 | Ptyr_pPase_sf | Homologous_superfamily |
Pfam: PF04722
Catalyzed reactions (Rhea), 2 shown:
- O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate (RHEA:20629)
- O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate (RHEA:47004)
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1W2PQ64-F1 | 94.59 | 0.89 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION, GOBP_MRNA_3_END_PROCESSING, GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION, GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY, GOBP_MRNA_PROCESSING, GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY, GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHATASE_ACTIVITY, GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY, GOBP_MRNA_METABOLIC_PROCESS
GO Biological Process (4): termination of RNA polymerase II transcription (GO:0006369), mRNA 3’-end processing (GO:0031124), regulation of transcription by RNA polymerase II (GO:0006357), mRNA processing (GO:0006397)
GO Molecular Function (4): RNA polymerase II CTD heptapeptide repeat phosphatase activity (GO:0008420), phosphoprotein phosphatase activity (GO:0004721), protein serine/threonine phosphatase activity (GO:0004722), hydrolase activity (GO:0016787)
GO Cellular Component (2): mRNA cleavage and polyadenylation specificity factor complex (GO:0005847), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| DNA-templated transcription termination | 1 |
| mRNA processing | 1 |
| RNA 3’-end processing | 1 |
| regulation of DNA-templated transcription | 1 |
| RNA processing | 1 |
| mRNA metabolic process | 1 |
| protein serine/threonine phosphatase activity | 1 |
| RNA polymerase II CTD heptapeptide repeat modifying activity | 1 |
| phosphatase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| phosphoprotein phosphatase activity | 1 |
| catalytic activity | 1 |
| mRNA cleavage factor complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
374 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SSU72L5 | SYMPK | Q92797 | 207 |
| SSU72L5 | PCF11 | O94913 | 207 |
| SSU72L5 | CSTF3 | Q12996 | 207 |
| SSU72L5 | CTDP1 | Q9Y5B0 | 207 |
| SSU72L5 | WDR82 | Q6UXN9 | 206 |
| SSU72L5 | GTF2B | Q00403 | 206 |
| SSU72L5 | CPSF1 | Q10570 | 206 |
| SSU72L5 | CPSF3 | Q9UKF6 | 205 |
| SSU72L5 | CPSF2 | Q9P2I0 | 205 |
| SSU72L5 | SUPT5H | O00267 | 205 |
| SSU72L5 | PIN1 | Q13526 | 204 |
| SSU72L5 | WDR33 | Q9C0J8 | 204 |
| SSU72L5 | RPAP2 | Q8IXW5 | 204 |
| SSU72L5 | POLR2B | P30876 | 194 |
| SSU72L5 | POLR2A | P24928 | 188 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1W2PQ27, A0A1W2PQ64, A0A1W2PQC6, A0A1W2PQD8, A0A1W2PQJ5, A0A1W2PR75, A2AV36, A4QN59, A6QQV6, D4A1F2, F1RA39, G5E8F4, J9SQF3, O00142, O42868, O55239, O95050, O95932, O97972, P0CR76, P0CR77, P10938, P40261, P40936, P53538, Q01841, Q22453, Q32LP9, Q4R7D0, Q566Y1, Q5M9G7, Q5RFR7, Q5U4E8, Q5XG58, Q62160, Q6C195, Q6CQ61, Q6DE00, Q6FMU7, Q6PCI6
Diamond homologs: A0A1W2PQ27, A0A1W2PQ64, A0A1W2PQC6, A0A1W2PQD8, A0A1W2PQJ5, A0A1W2PR75, O42868, P0CR76, P0CR77, P53538, Q17QI2, Q22453, Q2HFZ9, Q2UPU5, Q4IPC8, Q4KLK9, Q4WHY5, Q558Z3, Q5ZJQ7, Q6BYP7, Q6C195, Q6CQ61, Q6FMU7, Q6NRQ7, Q6PC19, Q75E60, Q7SFY0, Q9CY97, Q9NP77
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1291 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:4233393:T:C | F36L | 0.978 |
| 11:4233395:T:A | F36L | 0.978 |
| 11:4233395:T:G | F36L | 0.978 |
| 11:4233600:T:C | F105L | 0.966 |
| 11:4233602:T:A | F105L | 0.966 |
| 11:4233602:T:G | F105L | 0.966 |
| 11:4233456:T:C | F57L | 0.960 |
| 11:4233458:T:A | F57L | 0.960 |
| 11:4233458:T:G | F57L | 0.960 |
| 11:4233563:G:C | K92N | 0.959 |
| 11:4233563:G:T | K92N | 0.959 |
| 11:4233864:T:C | F193L | 0.951 |
| 11:4233866:C:A | F193L | 0.951 |
| 11:4233866:C:G | F193L | 0.951 |
| 11:4233579:T:C | F98L | 0.933 |
| 11:4233581:T:A | F98L | 0.933 |
| 11:4233581:T:G | F98L | 0.933 |
| 11:4233580:T:C | F98S | 0.930 |
| 11:4233342:A:C | S19R | 0.927 |
| 11:4233344:C:A | S19R | 0.927 |
| 11:4233344:C:G | S19R | 0.927 |
| 11:4233694:T:A | V136E | 0.908 |
| 11:4233729:G:C | A148P | 0.904 |
| 11:4233610:T:A | I108N | 0.902 |
| 11:4233561:A:G | K92E | 0.895 |
| 11:4233613:T:C | F109S | 0.892 |
| 11:4233580:T:G | F98C | 0.891 |
| 11:4233607:T:A | V107D | 0.888 |
| 11:4233548:A:C | R87S | 0.886 |
| 11:4233548:A:T | R87S | 0.886 |
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.